Ninety One SA PTY Ltd Cuts Stake in Johnson & Johnson $JNJ

Ninety One SA PTY Ltd lessened its stake in Johnson & Johnson (NYSE:JNJ) by 22.0% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 77,770 shares of the company’s stock after selling 21,921 shares during the quarter. Johnson & Johnson accounts for approximately 2.1% of Ninety One SA PTY Ltd’s holdings, making the stock its 13th biggest position. Ninety One SA PTY Ltd’s holdings in Johnson & Johnson were worth $14,328,000 at the end of the most recent reporting period.

Several other institutional investors also recently bought and sold shares of the company. Heritage Oak Wealth Advisors LLC lifted its stake in shares of Johnson & Johnson by 3.5% in the third quarter. Heritage Oak Wealth Advisors LLC now owns 1,639 shares of the company’s stock worth $304,000 after buying an additional 55 shares in the last quarter. Lifestyle Asset Management Inc. lifted its position in Johnson & Johnson by 3.4% in the 3rd quarter. Lifestyle Asset Management Inc. now owns 1,683 shares of the company’s stock valued at $312,000 after acquiring an additional 56 shares in the last quarter. Wynn Capital LLC boosted its stake in Johnson & Johnson by 0.4% during the 3rd quarter. Wynn Capital LLC now owns 15,930 shares of the company’s stock valued at $2,954,000 after purchasing an additional 57 shares during the last quarter. Defined Financial Planning LLC increased its holdings in shares of Johnson & Johnson by 3.0% in the 3rd quarter. Defined Financial Planning LLC now owns 1,926 shares of the company’s stock worth $365,000 after purchasing an additional 57 shares in the last quarter. Finally, Trail Ridge Investment Advisors LLC raised its stake in shares of Johnson & Johnson by 0.9% in the third quarter. Trail Ridge Investment Advisors LLC now owns 6,375 shares of the company’s stock worth $1,182,000 after purchasing an additional 57 shares during the last quarter. 69.55% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several research firms recently commented on JNJ. Daiwa America upgraded Johnson & Johnson from a “hold” rating to a “strong-buy” rating in a report on Monday, October 20th. Scotiabank began coverage on shares of Johnson & Johnson in a research note on Thursday, November 13th. They issued a “sector outperform” rating and a $230.00 price target for the company. JPMorgan Chase & Co. increased their price objective on shares of Johnson & Johnson from $185.00 to $200.00 and gave the company a “neutral” rating in a research report on Tuesday, September 16th. Bank of America lifted their target price on shares of Johnson & Johnson from $204.00 to $220.00 and gave the stock a “neutral” rating in a research report on Monday, December 15th. Finally, Loop Capital set a $190.00 price target on Johnson & Johnson in a report on Wednesday, October 22nd. Four analysts have rated the stock with a Strong Buy rating, fourteen have assigned a Buy rating and nine have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, Johnson & Johnson presently has a consensus rating of “Moderate Buy” and an average price target of $211.25.

Johnson & Johnson Stock Up 0.1%

JNJ opened at $207.26 on Friday. Johnson & Johnson has a 1-year low of $140.68 and a 1-year high of $215.18. The firm’s 50 day simple moving average is $201.17 and its two-hundred day simple moving average is $182.85. The company has a current ratio of 1.07, a quick ratio of 0.80 and a debt-to-equity ratio of 0.50. The company has a market capitalization of $499.35 billion, a PE ratio of 20.01, a PEG ratio of 2.13 and a beta of 0.34.

Johnson & Johnson (NYSE:JNJ) last posted its quarterly earnings data on Wednesday, August 30th. The company reported $2.26 EPS for the quarter. Johnson & Johnson had a return on equity of 32.73% and a net margin of 27.26%.The firm had revenue of $24.02 billion during the quarter. As a group, equities analysts forecast that Johnson & Johnson will post 10.58 EPS for the current year.

Johnson & Johnson Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 10th. Investors of record on Tuesday, February 24th will be paid a dividend of $1.30 per share. The ex-dividend date is Tuesday, February 24th. This represents a $5.20 dividend on an annualized basis and a dividend yield of 2.5%. Johnson & Johnson’s payout ratio is 50.19%.

About Johnson & Johnson

Johnson & Johnson is a multinational healthcare company headquartered in New Brunswick, New Jersey, that develops, manufactures and markets a broad range of products across pharmaceuticals, medical devices and previously consumer health. Founded in 1886 by the Johnson family, the company has grown into a global healthcare organization with operations and sales in many countries around the world.

The company’s pharmaceuticals business, organized largely under its Janssen research and development organization, focuses on prescription medicines across therapeutic areas such as immunology, infectious disease, oncology and neuroscience.